InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Martin Patricia A.. Director active across 1 company, notably AN2 Therapeutics, Inc.. In total, 3 reports have been published. History available since 19 December 2024. The latest transaction was filed on 10 October 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations